Costabel, Ulrich

Overview

Works:	105 works in 126 publications in 3 languages and 413 library holdings
Roles:	Contributor, Author, Editor, Other, dgs

Publication Timeline

Most widely held works by Ulrich Costabel

Atlas of bronchoalveolar lavage by Ulrich Costabel( Book )

10 editions published between 1993 and 1998 in 3 languages and held by 71 WorldCat member libraries worldwide

Lunge und Arbeitswelt by N Konietzko( )

1 edition published in 1990 in German and held by 22 WorldCat member libraries worldwide

In diesem Buch wird die Einwirkung von Schadstoffen am Arbeitsplatz auf die Atemwege und das Lungenparenchym sowie deren Reaktion dargestellt. Neu ist die Einbeziehung der 1989 revidierten Berufskrankheitenverordnung. Die einzelnen Krankheitsentitäten, die mit spezifischen Schadstoffen am Arbeitsplatz in Zusammenhang stehen, werden aus der Sicht der Arbeitsmedizin, der Epidemiologie, Pathologie, Pathogenese und Klinik systematisch abgehandelt. Fragen der Prävention und der Begutachtung erhalten dabei einen besonderen Stellenwert. Die diagnostische Relevanz der Computertomographie, bronchoalveolären Lavage, des Schadstoffnachweises im Gewebe und von Provokationstests für die Beurteilung schadstoffinduzierter Erkrankungen wird aufgezeigt. Ziel dieses Buches ist es, die Zusammenarbeit von Arbeitsmedizinern und Pneumologen zu vertiefen und mögliche Zusammenhänge zwischen Arbeit und Krankheit aufzuzeigen

Seltene Lungenerkrankungen( )

1 edition published in 2022 in German and held by 21 WorldCat member libraries worldwide

Pneumologie ein historisches Kaleidoskop ; Überraschendes, Kurioses, Lehrreiches ; 22 Tabellen( Book )

1 edition published in 2011 in German and held by 20 WorldCat member libraries worldwide

Klinische Pneumologie das Referenzwerk für Klinik und Praxis( Book )

1 edition published in 2014 in German and held by 19 WorldCat member libraries worldwide

Sarcoidosis by European Respiratory Society( Book )

3 editions published in 2005 in English and held by 18 WorldCat member libraries worldwide

Sarcoidosis by M Drent( )

2 editions published in 2005 in English and held by 17 WorldCat member libraries worldwide

A wide range of acute and chronic pulmonary disorders are capable of diffusely affecting the lung parenchyma with variable amounts of inflammation and fibrosis. A variety of agents and clinical conditions have been associated with interstitial lung disorders. Sarcoidosis is one of the most common causes of idiopathic interstitial lung disease. Clinical presentation can range from asymptomatic to severe respiratory symptoms. Sarcoidosis is considered as a multisystemic disease and chest physicians are frequently involved in the evaluation and management of this disease. The treatment of sarcoid

WASH OUT KINETICS AND EFFICACY OF A MODIFIED LAVAGE TECHNIQUE FOR PULMONARY ALVEOLAR PROTEINOSIS by Francesco Bonella( )

1 edition published in 2015 in English and held by 12 WorldCat member libraries worldwide

Role of anti-DFS70 antibodies in idiopathic interstitial pneumonia and in connective tissue disease associated interstitial lung disease by Yan Lyu( )

1 edition published in 2017 in English and held by 10 WorldCat member libraries worldwide

Generalisierte Lungenparenchymerkrankungen by N Konietzko( )

2 editions published between 1990 and 2012 in German and held by 7 WorldCat member libraries worldwide

Generalisierte Lungenparenchymerkrankungen, frtiher auch interstitielle Lungener krankungen genannt, stellen eine atiologisch sehr unterschiedliche Krankheitsgruppe dar: Zu ihnen zahlen durch Inhalation anorganischer und organischer Staube bedingte Erkrankungen wie Asbestose oder allergische Alveolitis ebenso wie infektios und me dikamenWs hervorgerufene Lungenparenchymschaden wie etwa die Pneumocystis-ca rinii-Pneumonie oder die Bleomycinlunge, Ein Gutteil der generalisierten Lungenparen chymerkrankungen ist atiologtsch nicht geklart, nosologisch aber sehr gut definiert, wie etwa die idio

Evidence-based respiratory medicine by Peter G Gibson( Book )

2 editions published between 2005 and 2008 in English and held by 4 WorldCat member libraries worldwide

Gibson (John Hunter Hospital, Newcastle, Australia) compiles six chapters investigating the practice of evidence-based respiratory medicine, as it applies to asthma, chronic obstructive pulmonary disease, infection--including bronchitis, sinusitis, pneumonia, pulmonary tuberculosis, cystic fibrosis, and influenza--respiratory failure, sleep-disordered breathing, diffuse lung disease, pleural disease, and thromboembolism. Each chapter is divided into four to eight sections, in which an international group of doctors describe diagnostic strategies, therapeutics, and treatments such as respiratory rehabilitation, oxygen therapy, lung volume reduction, corticosteroids, and complementary medicine. A CD-ROM is provided. Annotation :2006 Book News, Inc., Portland, OR (booknews.com)

Pulmonary complications of hematological disorders( Book )

2 editions published in 2005 in English and held by 4 WorldCat member libraries worldwide

Sarcoidosis by Robert P Baughman( )

3 editions published between 2005 and 2010 in English and held by 3 WorldCat member libraries worldwide

This guide analyzes molecular techniques for studies of the infectious causes of sarcoidosis; recent discoveries on the genetics of sarcoidosis; methods for the evaluation of the sarcoidosis patient; areas commonly affected by sarcoidosis including the skin, eyes, and liver; the musculoskeletal manifestations of the disease; various therapies in sarcoidosis including alternatives to corticosteroids; the current literature on the quality-of-life of the sarcoidosis patient; and rare manifestations of the disease. This reference serves as a comprehensive source on the many aspects of sarcoidosis ranging from the basic science and pathophysiology of the disease to patient evaluation and treatment-providing a detailed analysis of the pulmonary aspects of the condition including chapters on radiographic manifestations, bronchoalveolar lavage research, pulmonary function studies, and proposed markers for the diagnosis and management of the disease

Charakterisierung des bronchoalveolären Zellmusters bei Respiratorischer Bronchiolitis-Interstitieller Lungenerkrankung (RB-ILD) : Hinweise für eine definierte Entzündung und diagnostische Aspekte by Julie Bloem( )

2 editions published in 2020 in German and held by 3 WorldCat member libraries worldwide

Der chronische Zigarettenabusus stellt den wichtigsten Risikofaktor für die Entstehung entzündlicher Veränderungen der kleinen Atemwege dar. Diese sogenannte Respiratorische Bronchiolitis (RB) zeichnet sich histologisch durch eine Entzündung mit Vermehrung von Pigmentmakrophagen im Lungeninterstitium aus. Treten zudem Symptome auf oder kommt es zu einer Verschlechterung der Lungenfunktion bzw. zu radiologischen Veränderungen wird dies als Respiratorische Bronchiolitis-Interstitielle Lungenerkrankung (RB-ILD) bezeichnet. Die bronchoalveoläre Lavage (BAL) mit Differential- und Immunzytologie bildet einen wichtigen diagnostischen Ansatz bei der RB-ILD und vielen weiteren Lungenerkrankungen. In der vorgelegten Studie wurden 21 RB-ILD-Patienten im Hinblick auf die diagnostischen Methoden bei dieser Erkrankung (insbesondere BAL, Lungenfunktion und HRCT) analysiert und die Ergebnisse mit 22 Patienten aus Kontrollgruppen (Sarkoidose und Gesunde) ohne Zigarettenabusus verglichen. Bei 86% aller RB-ILD-Patienten zeigte sich in der BAL neben der Vermehrung der Pigmentmakrophagen eine signifikante Erhöhung der Natürlichen Killer T-Zellen in Kombination mit der Vermehrung mindestens vier anderer Lymphozyten-Subtypen (B-Zellen, CD4+CD25+T-Lymphozyten sowie den CD4+CD103+T-Lymphozyten). Das Zellmuster lässt auf eine spezifische mit der RB-ILD-assoziierte Entzündung schließen, wobei Zellen sowohl des angeborenen als auch des erworbenen Immunsystems durch den chronischen Zigarettenabusus in der BAL erhöht sind. Somit könnte es sich bei der RB-ILD um eine eigenständige Manifestationsform der ebenfalls raucherassoziierten COPD handeln. Die Expansion der regulatorischen CD4+CD25+T-Lymphozyten deutet ferner auf die Möglichkeit einer autoimmunologischen Komponente der Entzündung hin. Schließlich legen die Ergebnisse nahe, dass sich eine RB-ILD mittels BAL-Differential- und Immunzytologie diagnostizieren und von anderen Lungenerkrankungen abgrenzen lässt

Clinical guidelines and indications for bronchoalveolar lavage (BAL) : report of the European Society of Pneumology Task Group on BAL( Book )

2 editions published in 1992 in English and held by 3 WorldCat member libraries worldwide

Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis by Franck F Rahaghi( )

1 edition published in 2020 in English and held by 3 WorldCat member libraries worldwide

Azathioprine in connective tissue disease-associated interstitial lung disease data from a retrospective single centre study by Eda Burcu Börner( )

1 edition published in 2019 in English and held by 3 WorldCat member libraries worldwide

Seltene Lungenkrankheiten( Book )

1 edition published in 2002 in German and held by 3 WorldCat member libraries worldwide

Pirfenidone in Idiopathic Pulmonary Fibrosis: Expert Panel Discussion on the Management of Drug-Related Adverse Events by Ulrich Costabel( )

2 editions published in 2014 in English and held by 3 WorldCat member libraries worldwide

Pirfenidone is currently the only approved therapy for idiopathic pulmonary fibrosis, following studies demonstrating that treatment reduces the decline in lung function and improves progression-free survival. Although generally well tolerated, a minority of patients discontinue therapy due to gastrointestinal and skin-related adverse events (AEs). This review summarizes recommendations based on existing guidelines, research evidence, and consensus opinions of expert authors, with the aim of providing practicing physicians with the specific clinical information needed to educate the patient and better manage pirfenidone-related AEs with continued pirfenidone treatment. The main recommendations to help prevent and/or mitigate gastrointestinal and skin-related AEs include taking pirfenidone during (or after) a meal, avoiding sun exposure, wearing protective clothing, and applying a broad-spectrum sunscreen with high ultraviolet (UV) A and UVB protection. These measures can help optimize AE management, which is key to maintaining patients on an optimal treatment dose

Bronchoalveolar lavage by Robert P Baughman( )

2 editions published in 2007 in English and held by 3 WorldCat member libraries worldwide